Reference
Ohyama K, et al. Pharmacovigilance study of the association between dipeptidyl peptidase?4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS) Scientific Reports : 5 Aug 2022. Available from: URL: https://doi.org/10.1038/s41598-022-17366-x
Rights and permissions
About this article
Cite this article
Some DPP-4 inhibitors may increase risk of angioedema. Reactions Weekly 1919, 12 (2022). https://doi.org/10.1007/s40278-022-20954-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-20954-z